Baxter International Inc (BAX)

BAX on New York Consolidated

55.92USD
10:28am EST
Price Change (% chg)

$-0.46 (-0.82%)
Prev Close
$56.38
Open
$56.45
Day's High
$56.70
Day's Low
$55.90
Volume
749,817
Avg. Vol
4,102,589
52-wk High
$61.88
52-wk Low
$45.46

BAX

Chart for BAX

About

Baxter International Inc. (Baxter) develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a diversified healthcare company, Baxter applies a combination of expertise in... (more)

Overall

Beta: 0.40
Market Cap (Mil.): $33,989.35
Shares Outstanding (Mil.): 602.86
Annual Dividend: 1.16
Yield (%): 2.06

Financials

  BAX Industry Sector
P/E (TTM): 15.69 4.05 3.76
EPS (TTM): 13.51 -- --
ROI: -- 2.37 2.30
ROE: -- 3.77 2.82
view overview for:

UPDATE 3-U.S. FDA recalls Baxter hemodialysis system

* Devices need software update, to be done by end of Q1

29 Jan 2010

WRAPUP 1-Baxter, Becton forecasts set bar too low-analysts

CHICAGO, Jan 28 (Reuters) - Three top medical device companies issued financial outlooks for 2010 that analysts characterized as "conservative," as executives seemed reluctant to get too bullish in the face of a sluggish economy.

28 Jan 2010

UPDATE 3-Baxter posts higher earnings, matches Street view

* Matches Wall Street forecast (Adds conference call, analyst comment, byline, updates stock)

28 Jan 2010

STOCKS NEWS EUROPE-Grifols tracks peer Baxter lower

Shares in Spanish blood plasma firm Grifols fall 4.7 percent, tracking heavy losses in U.S. peer Baxter as investors sell after its in-line quarterly earnings.

28 Jan 2010

H1N1 flu shots given to 3.7 million in England

LONDON (Reuters) - Around 3.7 million people in England have been vaccinated against H1N1 flu, health authorities said on Thursday, and urged anyone in priority groups to have the shot now to ward off the virus in 2010.

21 Jan 2010

H1N1 flu shots given to 3.7 million in England

LONDON, Jan 21 (Reuters) - Around 3.7 million people in England have been vaccinated against H1N1 flu, health authorities said on Thursday, and urged anyone in priority groups to have the shot now to ward off the virus in 2010.

21 Jan 2010

Slovenia cuts H1N1 vaccine purchase from GSK 30 pct

LJUBLJANA, Jan 21 (Reuters) - Slovenia and British pharmaceutical company GlaxoSmithKline agreed to reduce the number of H1N1 flu vaccines that Slovenia will buy from GSK by 30 percent or 240,000 units, Slovenia's health ministry said on Thursday.

21 Jan 2010

Child H1N1 flu rate was much higher than thought

LONDON (Reuters) - One child in three caught the pandemic H1N1 flu in the first wave of infection in hard-hit areas of England in 2009 -- up to 10 times more than originally thought, scientists said on Thursday.

21 Jan 2010

UK child H1N1 flu rate was much higher than thought

* Children key to flu's spread, important vaccine targets

20 Jan 2010

FACTBOX-Governments cut H1N1 flu vaccines orders

Jan 12 (Reuters) - Governments in rich countries are cutting orders for H1N1 swine flu vaccines because of limited uptake and the fact one dose is enough to protect adults against the virus, rather than two as originally anticipated.

12 Jan 2010

Competitors

  Price Change
C.R. Bard, Inc. (BCR.N) $80.64 -0.72
Hospira, Inc. (HSP.N) $49.21 -0.21
Nektar Therapeutics (NKTR.OQ) $11.47 -0.24

  Earnings  vs    Estimates

view overview for: